Direct sellers seek clarity from FTC and FDA By: Claire Wilson There are a lot of cannabis companies out there that don’t care about the industry and are just trying to make a quick buck. They hurt all the hard work that’s been done. It’s good to make sure everybody
Kerry Brown
2020 to see issues stay at forefront; comp plan changes most urgent
By Teresa Craighead
What’s on the horizon for direct sellers at the beginning of 2020? Three issues that appear to stand above the rest are the growing regulations around the exploding CBD market, the direction and manner of Federal Trade Commission (FTC) scrutiny and where it will next focus, and the most problematic elements of complicated compensation plans.
CBD Regulations
The Federal Drug Administration (FDA) is struggling to develop regulations and guidance amdist the exploding demand for products containing cannabidiol (CBD).